Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

The Molecular Processes in the Trabecular Meshwork After Exposure to Corticosteroids and in Corticosteroid-Induced Ocular Hypertension.

Tytuł:
The Molecular Processes in the Trabecular Meshwork After Exposure to Corticosteroids and in Corticosteroid-Induced Ocular Hypertension.
Autorzy:
Liesenborghs I; .; .
Eijssen LMT; .; .
Kutmon M; .; .
Gorgels TGMF; .
Evelo CT; .; .
Beckers HJM; .
Webers CAB; .
Schouten JSAG; .; .
Źródło:
Investigative ophthalmology & visual science [Invest Ophthalmol Vis Sci] 2020 Apr 09; Vol. 61 (4), pp. 24.
Typ publikacji:
Journal Article
Język:
English
Imprint Name(s):
Publication: Brookline Ma : Association For Research In Vision And Ophthalmology (Arvo)
Original Publication: St. Louis, Mosby.
MeSH Terms:
Cell Cycle Proteins/*genetics
Dexamethasone/*pharmacology
Extracellular Matrix Proteins/*genetics
Gene Expression Regulation/*physiology
Glucocorticoids/*pharmacology
Ocular Hypertension/*chemically induced
Trabecular Meshwork/*drug effects
Animals ; Cattle ; Cells, Cultured ; Datasets as Topic ; Gene Expression Profiling ; Humans ; Ocular Hypertension/genetics ; Oligonucleotide Array Sequence Analysis ; RNA, Messenger/genetics ; Reverse Transcriptase Polymerase Chain Reaction ; Signal Transduction/drug effects ; Trabecular Meshwork/metabolism
References:
Invest Ophthalmol Vis Sci. 2015 Jun;56(6):3801-9. (PMID: 26066748)
Mol Vis. 2012;18:2001-11. (PMID: 22876128)
Mol Vis. 2019 Apr 25;25:237-254. (PMID: 31516309)
Acta Biomater. 2018 Apr 15;71:444-459. (PMID: 29524673)
Nucleic Acids Res. 2015 Apr 20;43(7):e47. (PMID: 25605792)
Exp Eye Res. 1979 Jul;29(1):27-43. (PMID: 510425)
Nucleic Acids Res. 2016 Jan 4;44(D1):D488-94. (PMID: 26481357)
J Ocul Biol. 2014 May;2(1):. (PMID: 25356439)
Invest Ophthalmol Vis Sci. 2003 Feb;44(2):473-85. (PMID: 12556371)
Exp Eye Res. 2018 Jun;171:164-173. (PMID: 29526795)
Trans Am Ophthalmol Soc. 1991;89:757-90. (PMID: 1687295)
Cancers (Basel). 2012 Nov 08;4(4):1180-211. (PMID: 24213504)
Eye (Lond). 2000 Jun;14 ( Pt 3B):503-14. (PMID: 11026980)
Invest Ophthalmol Vis Sci. 1992 Jun;33(7):2242-50. (PMID: 1607235)
Am J Ophthalmol. 2005 Jun;139(6):1136-7. (PMID: 15953461)
Invest Ophthalmol Vis Sci. 2015 Jul;56(8):4447-59. (PMID: 26193921)
BMC Med Genomics. 2009 Sep 10;2:58. (PMID: 19744340)
BMC Ophthalmol. 2017 Dec 29;17(1):268. (PMID: 29284449)
Exp Eye Res. 1991 Jun;52(6):681-90. (PMID: 1855543)
Nucleic Acids Res. 2012 Jan;40(Database issue):D1301-7. (PMID: 22096230)
Nucleic Acids Res. 2002 Jan 1;30(1):207-10. (PMID: 11752295)
Invest Ophthalmol Vis Sci. 2000 Dec;41(13):4133-41. (PMID: 11095606)
J Proteome Res. 2017 Oct 6;16(10):3753-3765. (PMID: 28920441)
Invest Ophthalmol Vis Sci. 2008 May;49(5):1886-97. (PMID: 18436822)
Invest Ophthalmol Vis Sci. 2011 Nov 07;52(12):8636-45. (PMID: 21980000)
Invest Ophthalmol. 1965 Apr;4:198-205. (PMID: 14283013)
Invest Ophthalmol Vis Sci. 2013 Oct 03;54(10):6502-9. (PMID: 23963164)
Nucleic Acids Res. 2015 Jan;43(Database issue):D1113-6. (PMID: 25361974)
Am J Physiol Cell Physiol. 2001 Jun;280(6):C1521-30. (PMID: 11350747)
Exp Eye Res. 2017 Feb;155:38-46. (PMID: 27939447)
Exp Eye Res. 2005 Mar;80(3):307-12. (PMID: 15721613)
Prog Retin Eye Res. 2017 Jan;56:58-83. (PMID: 27666015)
Curr Opin Ophthalmol. 2006 Apr;17(2):163-7. (PMID: 16552251)
Mol Vis. 2006 Feb 27;12:125-41. (PMID: 16541013)
PLoS One. 2017 Jan 9;12(1):e0169671. (PMID: 28068412)
Nucleic Acids Res. 2013 Jan;41(Database issue):D991-5. (PMID: 23193258)
Nucleic Acids Res. 2016 Jan 4;44(D1):D481-7. (PMID: 26656494)
Nucleic Acids Res. 2017 Jan 4;45(D1):D353-D361. (PMID: 27899662)
Invest Ophthalmol Vis Sci. 2011 Oct 17;52(11):8068-75. (PMID: 21911581)
Int J Mol Med. 1998 Feb;1(2):339-46. (PMID: 9852235)
Genome Res. 2003 Nov;13(11):2498-504. (PMID: 14597658)
Arch Ophthalmol. 2004 Oct;122(10):1492-7. (PMID: 15477461)
Invest Ophthalmol Vis Sci. 2018 Jan 1;59(1):21-30. (PMID: 29305605)
Invest Ophthalmol Vis Sci. 2019 May 1;60(6):1967-1978. (PMID: 31050723)
Ann Rheum Dis. 2014 Jul;73(7):1405-13. (PMID: 23727633)
Acta Ophthalmol. 2020 Feb;98(1):48-57. (PMID: 31197946)
Arch Ophthalmol. 1981 May;99(5):819-23. (PMID: 7236083)
Eye (Lond). 2006 Apr;20(4):407-16. (PMID: 15877093)
Nucleic Acids Res. 2016 Jan 4;44(D1):D457-62. (PMID: 26476454)
Int J Pharm. 2015 Feb 20;479(2):422-9. (PMID: 25556056)
Drugs Aging. 1999 Dec;15(6):439-50. (PMID: 10641955)
Am J Ophthalmol. 1988 Nov 15;106(5):607-12. (PMID: 3189477)
Exp Eye Res. 2017 Dec;165:7-19. (PMID: 28860021)
Invest Ophthalmol Vis Sci. 2002 Dec;43(12):3691-7. (PMID: 12454038)
Invest Ophthalmol Vis Sci. 2000 Jul;41(8):2070-5. (PMID: 10892845)
Cell Death Dis. 2010 Nov 04;1:e92. (PMID: 21368868)
Nucleic Acids Res. 2000 Jan 1;28(1):27-30. (PMID: 10592173)
PLoS Comput Biol. 2015 Feb 23;11(2):e1004085. (PMID: 25706687)
Int J Mol Med. 2018 Jan;41(1):164-172. (PMID: 29115373)
Aging Cell. 2012 Aug;11(4):569-78. (PMID: 22404905)
Proc Natl Acad Sci U S A. 2019 Jan 29;116(5):1714-1722. (PMID: 30651311)
BMC Bioinformatics. 2008 Sep 25;9:399. (PMID: 18817533)
Int J Dev Biol. 2004;48(8-9):1015-29. (PMID: 15558492)
Br J Ophthalmol. 1992 May;76(5):280-3. (PMID: 1356429)
Fed Proc. 1965 Nov-Dec;24(6):1274-8. (PMID: 5853148)
Substance Nomenclature:
0 (Cell Cycle Proteins)
0 (Extracellular Matrix Proteins)
0 (Glucocorticoids)
0 (RNA, Messenger)
7S5I7G3JQL (Dexamethasone)
Entry Date(s):
Date Created: 20200419 Date Completed: 20200821 Latest Revision: 20200821
Update Code:
20240104
PubMed Central ID:
PMC7401422
DOI:
10.1167/iovs.61.4.24
PMID:
32305042
Czasopismo naukowe
Purpose: To identify processes that contribute to corticosteroid-induced ocular hypertension and candidate target genes for treatment.
Methods: A systematic search identified five human microarray datasets investigating the effect of dexamethasone versus a control medium on trabecular meshwork (TM) tissue. After thorough quality control, samples of low quality were removed, and the datasets were integrated. Additionally, a bovine RNA-sequencing dataset allowed to investigate differences in gene expression profiling between cows with and without corticosteroid-induced ocular hypertension (responders vs. nonresponders). The obtained datasets were used as input for parallel pathway analyses. Significantly changed pathways were clustered into functional categories and the results were further investigated. A network visualizing the differences between the responders and nonresponders was created.
Results: Seven functional pathway clusters were found to be significantly changed in TM cells exposed to dexamethasone versus a control medium and in TM cells of responders versus nonresponders: collagen, extracellular matrix, adhesion, WNT-signaling, inflammation, adipogenesis, and glucose metabolism. In addition, cell cycle and senescence were only significantly changed in responders versus nonresponders. The network of the differential gene expression between responders and nonresponders shows many connections between the identified processes via shared genes.
Conclusions: Nine functional pathway clusters synthesize the molecular response to dexamethasone exposure in TM cells and are likely to be involved in the pathogenesis of corticosteroid-induced ocular hypertension.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies